Concentrations of inducible nitric oxide synthase (iNOS) and neuronal nitric oxide synthase (nNOS) in cerebrospinal fluid of patients with severe head injuries

Neurosurgery Quarterly

Volumn 13, Issue 2, 2003, Pages 117-124

  Uzan, Mustafa ^a,d   Tanriover, Necmettin ^a   Topal Sarikaya, Aysegul ^b   Tanriverdi, Taner ^a   Tuzgen, Saffet ^a   Cevherkesin, Birsen ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c MATERIALS INSTITUTE   (Turkey)

^d NONE   (Turkey)

Author keywords

Brain injury; Inducible nitric oxide synthase; Neuronal nitric oxide synthase; Nitric oxide synthase

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN VENTRICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HEAD INJURY; HUMAN; MALE; NERVE CELL LESION; PRIORITY JOURNAL; SCHOOL CHILD; TURKEY (REPUBLIC);

EID: 0037569580     PISSN: 10506438     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013414-200306000-00007     Document Type: Article

References (56)

1. McIntosh TK, Juhler M, Wieloch T. Novel pharmacological strategies in the treatment of experimental traumatic brain injury. J Neurotrauma 1998;15:731-69.
2. Choi DW. The excitotoxic concept. In: Welch KMA, Caplan LR, Reis DJ, Siesjo BK, Weir B, eds. Primer on cerebrovascular disease. New York: Academic Press; 1997:187-90.
3. Siesjo BK. Basic mechanisms of traumatic brain damage. Ann Emerg Med 1993;22:959-69.
4. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1998;1:623-34.
5. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988;336: 385-8.
6. Ikonomidou C, Turski L. Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonists. Metab Brain Dis 1996;11:125-41.
7. Wada K, Chatzipanteli K, Busto R. Dietrich WD. Role of nitric oxide in traumatic brain injury in rat. J Neurosurg 1998;89: 807-18.
8. 15N nitrate in biologic fluids. Anal Biochem 1982;126: 131.
9. Marletta MA. Nitric oxide synthase structure and mechanism. J Biol Chem 1993;268:12231-4.
10. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997;20:132-9.
11. Ayata C, Ayata G, Hara H, et al. Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. J Neurosci 1997;17:6908-17.
12. Shimizu-Sasamata M, Bosque-Hamilton P, Huang PL, Moskowitz MA, Lo EH. Attenuated neurotransmitter release and spreading depression-like depolarizations after focal ischemia in mutant mice with disrupted type I nitric oxide synthase gene. J Neurosci 1998; 18:9564-71.
13. Gorman LK, Williams MJ, Hum PD, Traystman RJ. Gender specific alterations in nitric oxide synthase isoforms and activity following traumatic brain injury in the rat [abstract]. Soc Neurosci Abst 1996;26:465.
14. Alagarsamy S, Dewitt DS, Johnson KM. Effects of moderate, central fluid percussion traumatic brain injury on nitric oxide synthase activity in rats. J Neurotrauma 1998;15:627-33.
15. Wada K, Chatzipanteli K, Kraydieh S, Busto R, Dietrich WD. Inducible nitric oxide synthase expression after traumatic brain injury and neuroprotection with aminoguanidine treatment in rats. Neurosurgery 1998;43:1427-36.
16. Gahm C, Holmin S, Mathiesen T. Temporal profiles and cellular sources of three nitric oxide synthase isoforms in the brain after experimental contusion. Neurosurgery 2000;46:169-77.
17. Clark RS, Kochanek PM, Schartz MA. Inducible nitric oxide synthase expression in cerebrovascular smooth muscle and neutrophils after traumatic brain injury in immature rats. Pediatr Res 1996;39: 784-90.
18. Orihara Y, Ikematsu K, Tsuda R, Naksono I. Induction of nitric oxide synthase by traumatic brain injury. Forensic Sci Int 2001; 123:142-9.
19. Clark RS, Kochanek PM, Obrist WD, et al. Cerebrospinal fluid and plasma nitrite and nitrate concentrations after head injury in humans. Neurol Crit Care 1996;24:1243-51.
20. Uzan M, Tanriover N, Bozkus H, Gumustas K, Guzel O, Kuday C. Nitric oxide (NO) metabolism in the cerebrospinal fluid of patients with severe head injury: inflammation as a possible cause of elevated NO metabolites. Surg Neurol 2001;56:350-6.
21. Bullock R, Chesnut RM, Clifton G, Ghajar J, et al. Guidelines for the management of severe head injury. Eur J Emerg Med 1996;3: 109-27.
22. Muizelaar JP, Marmarou A, DeSalles AAF, et al. Cerebral blood flow and metabolism in severely head-injured children. Part 1: relationship with GCS score, outcome, ICP, and PVI. J Neurosurg 1989;71:63-71.
23. Lowry OH, Rosebroegh NJ, Farr AL, Randall RJ. Protein measurement with the Folin-phenol reagent. J Biol Chem 1951;193: 265-75.
24. Baker SP, O'Neill B, Haddon W, Jr, Long WB. The Injury Severity Score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974;14:187-96.
25. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975 Mar 1;1(7905):480-4.
26. Moncada S, Palmer RJM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43: 109-42.
27. Suzuki Y, Satoh S, Oyama H, Takayusu M, Shibuya M. Regional differences in the vasodilator response to vasopressin in canine cerebral arteries in vivo. Stroke 1993;24:1049-54.
28. Tsutsui M, Milstien S, Katusic ZS. Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. Circ Res 1996;79:336-42.
29. Radomski MW, Palmer RMJ, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987;148:1482-9.
30. Kubus P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88:4651-5.
31. Moncada S, Higgs. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-11.
32. Rao VLR, Butterworth RF. Neuronal nitric oxide synthase and hepatic encephalopathy. Metab Brain Dis 1998;13:175-89.
33. Moncada S. The L-arginine: nitric oxide pathway (the 1991 Ulf von Euler Lecture). Acta Physiol Scand 1992;145:201-27.
34. Albina JE, Reichner JS. Nitric oxide in inflammation and immunity. New Horizons 1995;3:46-64.
35. Iadecola C, Xu X, Zhang F, et al. Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia. J Cereb Blood Flow Metab 1995;15:52-9.
36. Sakamoto KI, Fujisawa H, Koizumo H, et al. Effects of mild hypothermia on nitric oxide synthesis following contusion trauma in the rat. J Neurotrauma 1997;14:349-53.
37. Iadecola C, Xu X, Zhang F, et al. Inducible nitric oxide synthase gene expression following cerebral ischemia. J Cereb Blood Flow Metab 1995;15:378-84.
38. Suzuki Y, Osuka K, Noda A, et al. Nitric oxide metabolites in the cisternal cerebrospinal fluid of patient with subarachnoid hemorrhage. Neurosurgery 1997;41:807-12.
39. Jakob TD, Ochoa JB, Udekwu AO, et al. Nitric oxide production is inhibited in trauma patients. J Trauma 1993;35:590-7.
40. Ochoa JB, Udekwu O, Billiar TR, et al. Nitrogen oxide levels in patients after trauma and sepsis. Ann Surg 1991;214:621-5.
41. Visser JJ, Scholten R, Hoekman K. Nitric oxide synthesis in meningococcal meningitis. Ann Intern Med 1994;120:345-6.
42. Milstein S, Sakai N, Brew BJ, et al. Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases. J Neurochem 1994;63: 1178-80.
43. Kuiper MA, Visser JJ, Bergmans PLM, et al. Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease, and multiple system atrophy patients. J Neurol Sci 1994;121: 46-9.
44. Minc-Golomb D, Tsarfaty I, Schwartz JP. Expression of inducible nitric oxide synthase by neurons following exposure to endotoxin and cytokine. Br J Pharmacol 1994;112:720-2.
45. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-8.
46. Rao VLR, Baskaya MK, Dogan A, Rothstein JD, Dempsey RJ. Traumatic brain injury downregulates glial glutamate transporter (GLT-1 and GLAST) proteins in rat brain. J Neurochem 1998;70: 2020-7.
47. Clark RSB, Schiding JK, Kaczorowski SL, et al. Neutrophil accumutation after traumatic brain injury in rats: comparison of weight-drop and controlled cortical impact models. J Neurotrauma 1994; 11:499-506.
48. Gow AJ, Duran D, Malcolm S, Ischiropoulos H. Effects of peroxynitrite-induced protein modifications on thyrosine phosphorylation and degradation. FEBS Lett 1996;385:63-6.
49. Beckman JS, Ye YZ, Chen J, Conger JA. The interaction of nitric oxide with oxygen radicals and scavengers in cerebral ischemic injury. In: Siesjo BK, Wieloch T, eds. Advances in Neurology: Cellular and Molecular Mechanisms of Ischemic Brain Damage. Philadelphia: Lippincott-Raven; 1996:339-54.
50. 3H] nitroarginine binding. J Neurotrauma 1999;16:865-77.
51. Siesjö BK. Pathophysiology and treatment of focal cerebral ischemia: Part I - pathophysiology. J Neurosurg 1992;77:169-84.
52. Siesjö BK. Pathophysiology and treatment of focal cerebral ischemia: Part II - mechanisms of damage and treatment. J Neurosurg 1992;77:337-54.
53. Lynch DR, Dawson TM. Secondary mechanisms in neuronal trauma. Curr Opin Neurol 1994;7:510-6.
54. McIntosh TK. Neurochemical sequelae of traumatic brain injury: therapeutic implications. Cerebrovasc Brain Metab Rev 1994;6: 109-62.
55. Trotti D, Rossi D, Gjesdal O, et al. Peroxynitrite inhibits glutamate transporter subtypes. J Biol Chem 1996;271:5967-79.
56. 2 toxicity. Proc Natl Acad Sci USA 1992;89:9715-9.